GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹230 Cr | ₹132 Cr | ₹68 Cr | ₹59 Cr | ₹57 Cr |
What is the latest Total Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹230 Cr |
Mar2023 | ₹132 Cr |
Mar2022 | ₹68 Cr |
Mar2021 | ₹59 Cr |
Mar2020 | ₹57 Cr |
How is Total Liabilities of GENNEX LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹230 Cr | 73.82 | |
Mar2023 | ₹132 Cr | 94.30 | |
Mar2022 | ₹68 Cr | 15.49 | |
Mar2021 | ₹59 Cr | 3.44 | |
Mar2020 | ₹57 Cr | - |
Compare Total Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹310.6 Cr | -1.9% | 8.3% | -4.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | -0.1% | 1.3% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.7% | 0.5% | 47.2% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 0.4% | -1.5% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | -0.2% | 9% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 0.5% | -5.7% | -9.1% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -1.9% |
8.3% |
-4.8% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses